Effects of hydrogen sulfide on a rat model of sepsis-associated encephalopathy

Abstract

To investigate the interaction and involvement of sodium hydrosulfide (NaHS), a H₂S donor, on hippocampus of rats suffering from sepsis-associated encephalopathy, rats were subjected to cecal ligation and puncture (CLP)-induced sepsis. Adult male Sprague-Dawley rats were randomly divided into four groups: Sham group, CLP group, CLP+NaHS group and CLP+aminooxyacetic acid (AOAA, an inhibitor of H₂S formation) group. The four groups were observed at 3, 6, 9, 12 h after treatment. We examined hippocampal H₂S synthesis and the expression of cystathionine-β-synthetase (CBS), a major enzyme involved in the H₂S synthesis in hippocampus. CBS expression was detected by reverse transcription polymerase chain reaction (RT-PCR). The concentrations of inflammatory cytokines (TNF-α, IL-1β) were determined in hippocampus by using enzyme-linked immunosorbent assay (ELISA). Neuronal damage was studied by histological examination of hippocampus. In CLP group, H₂S synthesis was significantly increased in hippocampus compared with sham group and it peaked 3 h after CLP (P<0.05). Sepsis also resulted in a significantly upregulated CBS mRNA in hippocampus. The levels of TNF-α and IL-1β in the hippocampus were substantially elevated at each time point of measurement (P<0.05), and they also reached a peak value at about 3 h. Administration of NaHS significantly aggravated sepsis-associated hippocampus inflammation, as evidenced by TNF-α and IL-1β activity and histological changes in hippocampus. In septic rats pretreated with AOAA, sepsis-associated hippocampus inflammation was reduced. It is concluded that the rats subjected to sepsis may suffer from brain injury and elevated pro-inflammatory cytokines are responsible for the process. Furthermore, administration of H₂S can increase injurious effects and treatment with AOAA can protect the brain from injury.

Keywords

hydrogen sulfide / sepsis-associated encephalopathy / TNF-α / IL-1β

References

[1] ZhangH., ZhiL., MoochhalaS.M., et al.. Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture-induced sepsis. J Leukoc Biol, 2007, 82(4): 894-905

[2] AugusD.C., Linde-ZwirbleW.T., LidickerJ., et al.. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med, 2001, 29(7): 1303-1310

[3] DellingerR.P., LevyM.M., CarletJ. M., et al.. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med, 2008, 36(1): 296-327

[4] EbersoldtM., SharsharT., AnnaneD.. Sepsis-associated delirium. Intensive Care Med, 2007, 33(6): 941-950

[5] PytelP., AlexanderJ.J.. Pathogenesis of septic encephalopathy. Curr Opin Neurol, 2009, 22(3): 283-287

[6] TamizhselviR., MooreP. K., BhatiaM.. Hydrogen sulfide acts as a mediator of inflammation in acute pancreatitis: in vitro studies using isolated mouse pancreatic acinar cells. J Cell Mol Med, 2007, 11(2): 315-326

[7] HuL.F., WongP.T., MooreP.K., et al.. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem, 2007, 100(4): 1121-1128

[8] CollinM., AnuarF.B., MurchO., et al.. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol, 2005, 146(4): 498-505

[9] ZhangH., ZhiL., MooreP.K., et al.. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol, 2006, 290(6): L1193-L1201

[10] AbeK., KimuraH.. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neuroscience, 1996, 16(3): 1066-1071

[11] DanielR., MarkusS., MichaelA., et al.. Immunodesign of experimental sepsis by cecal ligation and puncture. Nature Protocols, 2009, 4(1): 31-36

[12] SzaboC.. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov, 2007, 6(11): 917-935

[13] MinamishimaS., BougakiM., SipsP.Y., et al.. Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation, 2009, 120(10): 888-896

[14] LiL, BhatiaM, ZhuYZ, et al.. Hydrogen sulfide is a novel mediator of lopopolysaccharide-induced inflammation in the mouse. FASEB J, 2005, 19(9): 1196-1198

[15] KafaI.M., UysalM., BakirciS., et al.. Sepsis induces apoptotic cell death in different regions of the brain in a rat model of sepsis. Acta Neurobiol Exp, 2010, 70(3): 246-260

[16] PapadopoulosM.C., DaviesD.C., MossR.F., et al.. Pathophysiology of septic encephalopathy: a review. Crit Care Med, 2000, 28(8): 3019-3024

[17] GreenR., ScottL.K., MinagarA., et al.. Sepsis associated encephalopathy (SAE): a review. Front Biosci, 2004, 9(5): 1637-1641

[18] AnnaneD.. Hippocampus: a future target for sepsis treatment. Intensive Care Med, 2009, 35(4): 585-586

[19] KimP. K., DeutschmanC. S.. Inflammatory responses and mediators. Surg Clin North Am, 2000, 80(3): 885-894

[20] BucovaM.. Role of cytokines in the development of local and systemic inflammation and septic shock. Vnitr Lek, 2002, 48(8): 755-762

[21] AlexanderJ.J., JacobA., CunninghamP., et al.. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int, 2008, 52(3): 447-456

[22] LynchA.M., WalshC., DelaneyA., et al.. Lipopolysa-ccharide-induced increase in signaling in hippocampus is abrogated by IL-10—a role for IL-1 beta?. J Neurochem, 2004, 88(3): 635-646

[23] SharsharT., AnnaneD., de la GrandmaisonG. L., et al.. The neuropathology of septic shock. Brain Pathol, 2004, 14(1): 21-33

[24] LacoboneE., Bailly-SalinJ., PolitoA., et al.. Sepsisassociated encephalopathy and its differential diagnosis. Crit Care Med, 2009, 37(10): S331-S336

[25] SiamiS., AnnaneD., SharsharT.. The encephalopathy in sepsis. Crit Care Clin, 2008, 24(1): 67-82

[26] WangJ., YangG.T.. Role of nuclear transcription factor-κB in endotoxin-induced shock in rats. J Huazhong Univ Sci Technol [Med Sci], 2005, 25(2): 174-177